| Dr Connie D Domingo, MD | |
|
92 Brick Rd, 3rd Floor, Marlton, NJ 08053-2177 | |
| (856) 489-4520 | |
| (856) 983-1065 |
| Full Name | Dr Connie D Domingo |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine |
| Location | 92 Brick Rd, Marlton, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902896889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P0010X | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine | 25MA06376400 (New Jersey) | Primary |
| Entity Name | Pediatric Rehabilitation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558811372 PECOS PAC ID: 2567746472 Enrollment ID: O20170221001026 |
News Archive
The test center, located at Renfrew High Street Car Park (PA4 8QL), is part of the largest network of diagnostic testing facilities created in British history.
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
Lexicon Pharmaceuticals, Inc. will present six posters summarizing the mechanism of action and safety of LX4211, a dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) currently in mid-stage development for type 2 diabetes, at the 72nd Scientific Sessions of the American Diabetes Association (ADA) in Philadelphia, Pennsylvania during the Saturday morning poster session on June 9, 2012.
Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.
Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. The study of the ADO index is published in the August 29 edition of the Lancet.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Connie D Domingo, MD Po Box 674, Marlton, NJ 08053-0674 Ph: (856) 489-4520 | Dr Connie D Domingo, MD 92 Brick Rd, 3rd Floor, Marlton, NJ 08053-2177 Ph: (856) 489-4520 |
News Archive
The test center, located at Renfrew High Street Car Park (PA4 8QL), is part of the largest network of diagnostic testing facilities created in British history.
BioWa, Inc. (BioWa) and NKT Therapeutics, Inc. (NKTT), announced today that they have entered into an agreement which provides NKTT with access to BioWa's patented POTELLIGENT(®) Technology platform for the development of antibody-dependent cellular cytotoxicity (ADCC) enhanced antibodies.
Lexicon Pharmaceuticals, Inc. will present six posters summarizing the mechanism of action and safety of LX4211, a dual inhibitor of sodium glucose transporters 1 and 2 (SGLT1 and SGLT2) currently in mid-stage development for type 2 diabetes, at the 72nd Scientific Sessions of the American Diabetes Association (ADA) in Philadelphia, Pennsylvania during the Saturday morning poster session on June 9, 2012.
Indiana University School of Medicine researchers Milan Radovich, PhD, and Bryan Schneider, MD, have discovered that the presence of circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the plasma of women's blood who have undergone chemotherapy prior to surgery for the treatment of stage 1, 2 or 3 triple negative breast cancer are critical indicators for the prediction of disease recurrence and disease-free survival.
Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. The study of the ADO index is published in the August 29 edition of the Lancet.
› Verified 5 days ago
Donald T Wu, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 92 Brick Rd, Marlton, NJ 08053 Phone: 856-281-3590 | |
Andre M Hu, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 525 Route 73 S Ste 300, Marlton, NJ 08053 Phone: 856-267-5319 Fax: 856-267-5483 | |
Theodore David Conliffe Jr., M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 999 Route 73 N Ste 301&401, Marlton, NJ 08053 Phone: 800-321-9999 | |
Selorm Takyi, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1001 Lincoln Dr W Ste E, Marlton, NJ 08053 Phone: 856-983-9001 Fax: 856-983-9011 | |
Reed Hofmann, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 230 N Maple Ave Ste B10, Marlton, NJ 08053 Phone: 856-396-2500 | |
Dr. Barbara Douglas, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 92 Brick Rd, Marlton, NJ 08053 Phone: 856-809-0689 Fax: 856-324-9006 | |
Mark Griffin, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 500 Lippincott Dr, Marlton, NJ 08053 Phone: 856-334-4100 Fax: 856-334-4015 |